Top Markets
Coin of the day
Asarina Pharma AB (publ) Asarina Pharma AB (publ)

Asarina Pharma AB (publ)

ASAP
株式のランク #40862
Asarina Pharma AB (publ) is a biotech enterprise, specializing in the research... Asarina Pharma AB (publ) is a biotech enterprise, specializing in the research and development of pharmaceutical products. Their key therapeutic agent, Sepranolone, is developed to address menstrual migraine and Tourette syndrome. Founded in 2005, this Solna, Sweden-based company was previously known as Umecrine Mood AB before officially changing its name to Asarina Pharma AB (publ) in 2016.
株価
$0.00312742
最終同期: 2024-10-01
時価総額
$70.81K
変化(1日)
-21.83%
変化(1年)
0.00%
SE
取引 Asarina Pharma AB (publ) (ASAP)

カテゴリー

Asarina Pharma AB (publ)(ASAP)のEPS
December 2023 時点のEPS TTM: $-0.06
Asarina Pharma AB (publ)の最新の財務報告と株価によると、同社の現在のEPS(TTM)は$-0.06です。2022年末には、EPSは$-0.07で、2021年のEPS$-0.19と減少でした。
Asarina Pharma AB (publ)のEPS履歴(2017から2026まで)
各年末時点のEPS
EPS 変化
2026 (TTM) $-0.06 -5.83%
2023 $-0.06 -17.03%
2022 $-0.07 -63.52%
2021 $-0.19 -61.62%
2020 $-0.49 5.60%
2019 $-0.46 49.64%
2018 $-0.31 -36.60%
2017 $-0.49 0.00%
同様の企業または競合他社のEPS
企業 EPS EPSの差
$17.32 -30,754.87%
US
$27.74 -49,197.35%
NL
- -
CH
- -
KR
$13.70 -24,347.96%
BE